Abstract: This clutch control device includes a clutch apparatus configured to connect and disconnect power transmission between a prime mover and an output target, a clutch actuator configured to output a driving force for actuating the clutch apparatus, a control unit configured to drive the clutch actuator, and an operating force transmission mechanism configured to transmit an operating force of a driver with respect to a clutch operator to the clutch apparatus, an operating force sensor configured to detect the operating force of the driver is provided in the operating force transmission mechanism, and the control unit drives the clutch actuator according to a detection value of the operating force sensor.

Abstract: A work machine information collection system includes a work machine including an operation hardware assembly and a server communicably connected to each other, and a data collection processor configured or programmed to include an operation data output to output an operation data corresponding to an operation state of the operation hardware assembly, a determiner configured or programmed to determine whether not the operation data satisfies a determination condition to determine whether or not to transmit the operation data output by the operation data output to the server, and a communicator configured or programmed to transmit the operation data to the server when the determiner determines that the operation data satisfies the determination condition.

Abstract: A cleaning apparatus includes: a cleaning tank that defines a cleaning space for cleaning a wafer; a wafer rotation mechanism that is arranged inside the cleaning tank and holds and rotates the wafer; a cleaning member that contacts and cleans a surface of the wafer, is rotatable around a central axis extending in a lateral direction, and has a length in an axial direction longer than a radius of the wafer; a swing mechanism that swings the cleaning member around a swing axis located inside the cleaning tank to move the cleaning member from a retracted position outside of the wafer to a cleaning position directly above the wafer; a second cleaning means that cleans the surface of the wafer; and a second swing mechanism that swings the second cleaning means around a second swing axis located inside the cleaning tank to pass directly above a center of the wafer.

Abstract: A method predicts an amount of an analyte in a urine specimen collected in a target time zone. The method includes measuring an amount of an analyte in a urine specimen collected in a predetermined time zone after an administration of a chelating agent and b) predicting, from the measured amount of the analyte in the urine specimen collected in the predetermined time zone, the amount of the analyte in the urine specimen collected in the target time zone on the basis of a correlation between amounts of analyte in urine specimens in the predetermined time zone and amounts of analyte in urine specimens in the target time zone. The amounts of the analyte in the urine specimens in the predetermined time and the target time zone are measured before predicting the amount of the analyte in the urine specimen collected in the target time zone.

Abstract: A program update system for a working machine, includes a machine body, a working device to be used for work, the working device being provided to the machine body, a storage device to store an update program for the machine body or the working device, and an update controller to control the update program. The update controller executes the update program for the working device based on a state of the machine body or the working device.

Abstract: To provide a communication system for a working machine capable of easily updating setting information of a working device connected to the machine body. A communication system for a working machine includes: a machine body; a working device provided on the machine body to perform work; a communicator device to receive setting information relating to setting of the machine body or the working device; and a control device, the communication system being configured to transmit the setting information from a server to the working machine. The server determines a transmitting operation to the working machine based on a response result of the communicator device when the server communicates with the communicator device to transmit the setting information, and the communicator device determines an accepting operation for the setting information depending on a status of the working machine.

Abstract: A method predicts an amount of an analyte in a urine specimen collected in a target time zone. The method includes measuring an amount of an analyte in a urine specimen collected in a predetermined time zone after an administration of a chelating agent and b) predicting, from the measured amount of the analyte in the urine specimen collected in the predetermined time zone, the amount of the analyte in the urine specimen collected in the target time zone on the basis of a correlation between amounts of analyte in urine specimens in the predetermined time zone and amounts of analyte in urine specimens in the target time zone. The amounts of the analyte in the urine specimens in the predetermined time and the target time zone are measured before predicting the amount of the analyte in the urine specimen collected in the target time zone.

Abstract: A hydrodynamic bearing device includes a sleeve having a bearing bore substantially at a center portion, a shaft inserted in the bearing bore in a rotatable manner, a thrust plate for supporting an end of the shaft in the thrust direction and an upper retaining portion that has an opening portion through which the shaft passes and covers the upper surface of the sleeve. A radial hydrodynamic bearing is formed between the bearing bore of the sleeve and the shaft, while a thrust hydrodynamic bearing is formed between the thrust plate and an end of the shaft. A first space is formed between the upper surface of the sleeve and the upper retaining portion. A second space is formed between the upper retaining portion and a step portion.

Abstract: An epoxy resin cured article has a high glass transition temperature and low dissipation factor. An epoxy resin composition from which the cured article can be having excellent solubility in solvents is used to produce the cured articles. A polyester as a curing agent of an epoxy resin composition having an aromatic polyhydroxy coumpound residue including an aryloxycarbonyl group at the molecule of the terminal, an aromatic polyvalent hydrocarbon group residue, and bulky structure, is used. Since the curing agent behaves as a polyfunctional curing agent, a cured article produced therefrom has a high crosslink density. Since highly polar hydroxyl groups are not formed during curing, a cured article has high glass transition temperature and a low dissipation factor. The cured article does not release low molecular weight carboxylic acids though hydrolysis of ester bonds at crosslinked bonds.

Abstract: A compound of a formula (1) and pharmacologically acceptable salts thereof: wherein R1 represents hydrogen, halogen, alkyl or hydroxyl; R2 represents hydrogen or halogen; R3 represents hydrogen, alkyl, hydroxyl, carboxyalkyl, alkoxycarbonylalkyl, alkylsulfonyl, alkoxycarbonylalkylsulfonyl, craboxyalkylsulfonyl or carboxyalkylcarbonyl; each of R4 and R5 represents hydrogen, halogen, alkyl, carbamoyl, alkoxy, carboxyl, alkoxycarbonyl, monoalkylcarbamoyl or dialkylcarbamoyl; R6 represents a heterocycle, hydrogen, alkyl, cycloalkyl, aralkyl, carboxyalkyl, alkoxycarbonyalkyl, aliphatic or aromatic acyl, carbamoyl, alkylsulfonyl, aryl, formimidoyl, 1-iminoalkyl, N-alkylforminidoyl or iminoarylmethyl; each of R7 and R8 represents hydrogen or alkyl; n represents 0, 1 or 2. The compound exhibits excellent activated blood coagulation factor X inhibitory activity and prevents or treats blood coagulation-related diseases.

Abstract: A hydrodynamic bearing device includes a sleeve having a bearing bore substantially at a center portion, a shaft inserted in the bearing bore in a rotatable manner, a thrust plate for supporting an end of the shaft in the thrust direction and an upper retaining portion that has an opening portion through which the shaft passes and covers the upper surface of the sleeve. A radial hydrodynamic bearing is formed between the bearing bore of the sleeve and the shaft, while a thrust hydrodynamic bearing is formed between the thrust plate and an end of the shaft. A first space is formed between the upper surface of the sleeve and the upper retaining portion. A second space is formed between the upper retaining portion and a step portion.

Abstract: Benzamidine derivatives of formula (I) or pharmaceutically acceptable salts thereof exhibit excellent inhibitory activity against factor Xa and are useful for treating or preventing blood coagulation disorders: 1

Abstract: A compound of a formula (1) and pharmacologically acceptable salts thereof: 1

Abstract: An epoxy resin cured article has a high glass transition temperature and low dissipation factor. An epoxy resin composition from which the cured article can be having excellent solubility in solvents is used to produce the cured articles. A polyester as a curing agent of an epoxy resin composition having an aromatic polyhydroxy coumpound residue including an aryloxycarbonyl group at the molecule of the terminal, an aromatic polyvalent hydrocarbon group residue, and bulky structure, is used. Since the curing agent behaves as a polyfunctional curing agent, a cured article produced therefrom has a high crosslink density. Since highly polar hydroxyl groups are not formed during curing, a cured article has high glass transition temperature and a low dissipation factor. The cured article does not release low molecular weight carboxylic acids though hydrolysis of ester bonds at crosslinked bonds.

Abstract: Benzamidine derivatives of formula (I) or pharmaceutically acceptable salts thereof exhibit excellent inhibitory activity against factor Xa and are useful for treating or preventing blood coagulation disorders: 1

Abstract: Benzamidine derivatives of formula (I) or pharmaceutically acceptable salts thereof exhibit excellent inhibitory activity against factor Xa and are useful for treating or preventing blood coagulation disorders: wherein R1 represents a hydrogen atom, a halogen atom, an alkyl group or a hydroxyl group; R2 represents a hydrogen atom, a halogen atom or an alkyl group, R3 represents a hydrogen atom, an optionally substituted alkyl group, an aralkyl group, an optionally substituted alkanoyl group or an optionally substituted alkylsulfonyl group, R4 and R5 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, an optionally substituted alkyl group, an alkoxy group, a carboxyl group, an alkoxycarbonyl group or an optionally substituted carbamoyl group, and R6 represents a substituted pyrrolidine group or substituted piperidine group.

Abstract: Compound of formula (I): ##STR1## [wherein: X represents an unsubstituted or substituted indolyl, indolinyl, azaindolyl, azaindolinyl, imidazopyridyl or imidazopyrimidinyl group; Y represents an oxygen or sulphur atom; Z represents a 2,4-dioxothiazolidin-5-ylidenylmethyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxooxazolidin-5-ylmethyl, 3,5-dioxooxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group; R represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a hydroxy group, a nitro group, an aralkyl group or a unsubstituted or substituted amino group; and m is an integer of from 1 to 5] have hypoglycemic and anti-diabetic activities.

Abstract: A strong metal plate having flexibility includes a flat portion, a plurality of first protuberances projecting from the flat portion in one direction of the thickness direction of the flat portion and a plurality of second protuberances projecting from the flat portion in the other direction of the thickness.

Abstract: Compounds of formula (I): ##STR1## [wherein: X represents an unsubstituted or substituted indolyl, indolinyl, azaindolyl, azaindolinyl, imidazopyridyl or imidazopyrinidinyl group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxo-thiazolidin-5-ylidenylmethyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxooxazolidin-5-ylmethyl, 3,5-dioxo-oxadiazolidin-2-ylmethyl or N-hydroxyureidom ethyl group; R represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a hydroxy group, a nitro group, an aralkyl group or a unsubstituted or substituted amino group; and m is an inzeger of from 1 to 5] have hypoglycemic and anti-diabetic activities.

Abstract: Compounds of formula (I): ##STR1## wherein: R.sup.1 is hydrogen or alkyl; R.sup.2 is alkylene; R.sup.3 is hydrogen, alkyl, alkoxy, alkylthio, halogen, nitro group, amino group, monoalkylamino, dialkylamino, aryl, or aralkyl; X is aryl, or aromatic heterocyclic; Y is oxygen, sulfur or a group of formula >N--R.sup.4, in which R.sup.4 is hydrogen, alkyl or acyl; and Z is a group of formula (Za), (Zb), (Zc) or (Zd): ##STR2## and salts thereof can be used to treat or prevent are included those arising from hyperlipidemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistant non-IGT (NGT), non-diagnostic glucose tolerance, insulin resistance, diabetic complications, fatty liver, polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM); in addition the compounds of the present invention have aldose reductase inhibitory activity.